Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung Cancer
2013 ◽
Vol 8
(3)
◽
pp. 369-372
◽
Keyword(s):
Phase Ii
◽
2012 ◽
Vol 7
(10)
◽
pp. 1594-1601
◽
Keyword(s):
Keyword(s):
Keyword(s):